This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
UC San Diego TMS Center is part of the only university-affiliated health system in San Diego and one of the nation’s most highly regarded academic departments of psychiatry. We were the first in San Diego to offer FDA cleared TMS treatment in 2009 and we recently enhanced our clinical capabilities to offer Deep TMS therapy with the Brainsway system.
Led by David Feifel, MD, PhD, an internationally recognized clinician-scientist, our TMS program is a leader in innovating the use of TMS therapy in conjunction with other cutting edge treatments. Deep TMS therapy at UC San Diego is a component of a comprehensive approach to treating psychiatric and neurological disorders which starts with a thorough review of each client’s history, current symptoms and past treatments, followed by a discussion of standard and innovative treatment options that may benefit them.
Please fill all the marked fields